Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.65
Price to sales ratio
1 541.15

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2756
CRMD
CorMedix Inc. - Common Stock
8.30 USD-0.12%+0.73%+14.01%-26.55%646.94 M USD
2764
RGNX
REGENXBIO Inc. - Common Stock
9.66 USD+3.09%+16.53%-0.92%-28.07%637.69 M USD
2779
HELP
Cybin Inc. - Common Stock
12.18 USD-8.01%-2.64%+54.18%+35.79%628.88 M USD
2788
AUTL
Autolus Therapeutics plc - American Depositary Shares
2.34 USD-0.85%-2.50%+60.27%+58.11%622.82 M USD

Frequently asked questions about Silence Therapeutics Plc American Depository Share

What is the Silence Therapeutics Plc American Depository Share stock price today?

The current price of Silence Therapeutics Plc American Depository Share (SLN) is 13.42. Over the past 24 hours, the stock has changed by -0.22%. Follow the SLN chart for real-time price dynamics.

What is the stock ticker of Silence Therapeutics Plc American Depository Share?

Silence Therapeutics Plc American Depository Share trades under the ticker SLN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Silence Therapeutics Plc American Depository Share stock going up?

SLN has changed by -0.59% over the last week, +16.09% over the last month, and +173.88% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Silence Therapeutics Plc American Depository Share?

Silence Therapeutics Plc American Depository Share currently has a market capitalization of 634.05 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Silence Therapeutics Plc American Depository Share earnings last quarter?

Last quarter, Silence Therapeutics Plc American Depository Share reported earnings of -0.09 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Silence Therapeutics Plc American Depository Share revenue for the last quarter?

Silence Therapeutics Plc American Depository Share reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Silence Therapeutics Plc American Depository Share net income for the last quarter?

Silence Therapeutics Plc American Depository Share reported net income of -12.27 M for the last quarter. The previous quarter showed -14.96 M, which means net income changed by +17.98%.

How many employees does Silence Therapeutics Plc American Depository Share have?

As of the latest available data, Silence Therapeutics Plc American Depository Share has 88 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Silence Therapeutics Plc American Depository Share stock?

You can buy Silence Therapeutics Plc American Depository Share (SLN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Silence Therapeutics Plc American Depository Share stock?

Investing in Silence Therapeutics Plc American Depository Share requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLN chart and related analysis on metatrader.com as part of your research.

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

News